10 bargain properties going under the hammer

Buying a home at auction can save you money, but preparation is key

MRNA Jan 2025 220.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

10.10

0.00

(0.00%)

As of 12:24PM EDT. Market open.

Loading interactive chart…

Yahoo Finance
Novavax's stock surges almost 300% in the past month
Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.
Investor's Business Daily
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Moderna stock is on the rise amid a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?
Barrons.com
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Drugmakers are aiming to launch this year’s shots by the beginning of September but have been waiting on the FDA to decide which strain of the virus to target. At their meeting on Wednesday, the FDA’s advisers nevertheless recommended that this year’s shots target JN.1, saying they expect a JN.1 shot to offer sufficient protection against the strain’s descendants.